Form PRE 14A - Other preliminary proxy statements:
SEC Accession No. 0000936392-04-000424
Filing Date
2004-04-27
Accepted
2004-04-27 14:18:06
Documents
3
Period of Report
2004-06-11

Document Format Files

Seq Description Document Type Size
1 PRELIMINARY PROXY STATEMENT a98367pre14a.htm PRE 14A 325132
2 GRAPHIC a98367a9836700.gif GRAPHIC 4976
3 GRAPHIC a98367a9836702.gif GRAPHIC 24774
  Complete submission text file 0000936392-04-000424.txt   356630
Mailing Address 10275 SCIENCE CENTER DRIVE SAN DIEGO CA 92121-1117
Business Address 10275 SCIENCE CENTER DRIVE SAN DIEGO CA 92121-1117 8585507500
LIGAND PHARMACEUTICALS INC (Filer) CIK: 0000886163 (see all company filings)

EIN.: 770160744 | State of Incorp.: DE | Fiscal Year End: 1231
Type: PRE 14A | Act: 34 | File No.: 000-20720 | Film No.: 04756463
SIC: 2834 Pharmaceutical Preparations